Crimean-Congo Hemorrhagic Fever Virus for Clinicians—Diagnosis, Clinical Management, and Therapeutics
Emerging Infectious Diseases·
- DOI
- 10.3201/eid3005.231648
- PMID
- 38666553
- PMCID
- PMC11060459
- OpenAlex
- W4393975280
- Study type
- Journal article
- Publisher
- Centers for Disease Control and Prevention (CDC)
- Article type
- journal-article
- Integrity
- current
Why this research matters now
Ongoing epidemiological concerns stem from extensive territorial reach, expansion risks, mutational flexibility, high lethality, and scarce preventive or therapeutic options.
Structured evidence summary
Research question
The article evaluates current diagnostic procedures, clinical management protocols, and available or experimental therapeutics for humans infected with the Crimean-Congo hemorrhagic fever virus.
Study design
The authors conducted a narrative synthesis of previously published literature to consolidate information regarding human disease manifestations.
Population and setting
The analysis targets individuals diagnosed with or exposed to the pathogen across endemic territories, with particular attention to clinical frameworks operating within the United States and European jurisdictions.
Main findings
Regulatory authorities in North America and Europe have not yet authorized any immunizations or antiviral drugs for this condition. Clinical protocols prioritize symptom management, while investigators continue to evaluate repurposed antiviral compounds and early-stage vaccine candidates.
Public-health relevance
Ongoing epidemiological concerns stem from extensive territorial reach, expansion risks, mutational flexibility, high lethality, and scarce preventive or therapeutic options.
Important limitations
The provided summary relies exclusively on the supplied abstract and bibliographic metadata, and full evaluation requires access to the complete original manuscript.
GIDS interpretation
This publication functions as a clinician-oriented consolidation of diagnostic and therapeutic resources for a high-mortality arbovirus. Its inclusion in literature tracking reinforces awareness of unmet medical needs and diagnostic gaps within emerging infectious disease monitoring frameworks, without implying alignment with active outbreak surveillance systems.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 11 auditable classifier relationships to diseases, places, topics, and study design.